{
  "docId": "019de076-0bfb-77a4-9766-824e83d61c36",
  "docSlug": "78f42e9d8d70fea2dc2370a17955f7e7",
  "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 52,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses a before-after-bridge framework to contrast existing therapy failure with Nuvalent's success.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-0bfb-77a4-9766-824e83d61c36/7",
  "deckHref": "/decks/019de076-0bfb-77a4-9766-824e83d61c36",
  "deckJsonHref": "/decks/019de076-0bfb-77a4-9766-824e83d61c36.json",
  "deckAnchorHref": "/decks/019de076-0bfb-77a4-9766-824e83d61c36#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.6,
        "x": 0.3,
        "y": 0.18
      },
      "kind": "diagram",
      "text": "Original tumor evolving into drug-resistant tumor via mutation",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed9b12e9-40cf-48d9-bae3-1899b84d5d3e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.6,
        "x": 0.3,
        "y": 0.45
      },
      "kind": "framework",
      "text": "Comparison of existing therapy vs Nuvalent therapy in normal vs mutated kinase scenarios",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74c19bb8-73d9-4491-82f2-22b390ae8502",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.07,
        "y": 0.56
      },
      "kind": "paragraph",
      "text": "Structural innovations designed to overcome drug-resistance due to kinase mutations",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a71e5f84-a406-4773-8c17-4367b5ca7829",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.17,
        "x": 0.07,
        "y": 0.42
      },
      "kind": "title",
      "text": "Kinase Resistance",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "255ac126-8c38-43bd-bc45-436e2bd783c7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem-Agitate-Solve (PAS)",
      "slug": "problem-agitate-solve-pas",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "38a8d6aa-4ad3-4082-ae89-2e6ea02ae249",
      "evidence": "paragraph/paragraph: Structural innovations designed to overcome drug-resistance due to kinase mutations",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "3c5ae9b2-ec04-46fa-9d5f-7303c4904b54",
      "evidence": "Contrasts the state of 'existing therapy' failure against 'Nuvalent therapy' success in the context of mutation.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 7,
      "from": 7,
      "beatId": "65550cb5-ee81-4f95-bbe3-0e8a0687e1c8",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Slide 7: Problem statement - Structural innovations designed to overcome drug-resistance due to kinase mutations",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "65aac5b7-e703-47fe-855e-79b350b26916",
      "evidence": "Slides 7-12 discuss the limitations of current treatments and the need for new solutions",
      "position": 0,
      "objective": "What is the cost of not addressing drug resistance in cancer treatment?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}